Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534878 | 0.84 | ESR1 (0.42) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL437002 | 0.83 | RARB (0.37) | KIF11GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL1306384 | 0.82 | GABRA1 (0.38) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL16626125 | 0.81 | ALDH1A1 (0.35) | KIF11GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL8960251 | 0.81 | RARB (0.48) | KIF11GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL14998069 | 0.79 | KIF11 (0.56) | KIF11ALDH1A1TSHRCES2CES1 | |
| SCHEMBL16747679 | 0.79 | KIF11 (0.56) | KIF11ALDH1A1TSHRCES2CES1 | |
| SCHEMBL1306505 | 0.79 | APP (0.41) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL19385736 | 0.79 | GABRA1 (0.34) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL8048738 | 0.79 | SLC2A1 (0.39) | GABRA1GABRG2GABRB3GABRA5GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111211355-A | High-voltage lithium ion battery electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-05-29 | — | — | CN | claimed |
| EP-3433239-B1 | SMALL MOLECULE INHIBITORS OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20250264649-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECH LLC (US) | 2025-08-21 | — | — | US | disclosed |
| US-12320999-B2 | High refractive index and highly birefringent solid organic materials | META PLATFORMS TECHNOLOGIES, LLC (US) | 2025-06-03 | — | — | US | disclosed |
| EP-4330736-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117203556-A | High refractive index and high birefringence solid organic material | 元平台技术有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-11766433-B2 | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-09-26 | — | — | US | disclosed |
| WO-2022232071-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2022-11-03 | — | — | WO | disclosed |
| US-20220342132-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | FACEBOOK TECHNOLOGIES, LLC | 2022-10-27 | — | — | US | disclosed |
| CN-113394451-A | Lithium ion battery electrolyte containing unsaturated bond silane additive and lithium ion battery | 杉杉新材料（衢州）有限公司 | 2021-09-14 | — | — | CN | disclosed |
| US-20150144927-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) | 2015-05-28 | — | — | US | disclosed |
| WO-2010063487-A1 | PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-06-10 | — | — | WO | disclosed |
| EP-0538310-B1 | ETHYNYLBENZOTHIOPHENE PESTICIDES | FMC CORP (US) | 1995-09-13 | — | — | EP | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| EP-0538310-A4 | ETHYNYLBENZOTHIOPHENE PESTICIDES | — | 1993-07-14 | — | — | EP | disclosed |
| EP-0538310-A1 | ETHYNYLBENZOTHIOPHENE PESTICIDES. | FMC CORP (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| WO-1992000672-A1 | ETHYNYLBENZOTHIOPHENE PESTICIDES | FMC CORPORATION (US) | 1992-01-23 | — | — | WO | disclosed |
| US-5073564-A | Photoactivated insecticides | FMC CORPORATION (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150144927-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LEF1, CORO1A, CORO1C | KIF11 3520/4885GABRA1 2049/4885GABRG2 3987/4885 |
| US-11766433-B2 | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer | AR, NR0B1, NCOA3 | KIF11 2798/4885GABRA1 1732/4885GABRG2 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.